These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 3355897

  • 1. Thrombasthenia with an abnormal platelet membrane glycoprotein IIb of different molecular weight.
    Jung SM, Yoshida N, Aoki N, Tanoue K, Yamazaki H, Moroi M.
    Blood; 1988 Apr; 71(4):915-22. PubMed ID: 3355897
    [Abstract] [Full Text] [Related]

  • 2. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
    Modderman PW, van Mourik JA, van Berkel W, Cordell JL, Morel MC, Kaplan C, Ouwehand WH, Huisman JG, von dem Borne AE.
    Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137
    [Abstract] [Full Text] [Related]

  • 3. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N.
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [Abstract] [Full Text] [Related]

  • 4. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
    Fournier DJ, Kabral A, Castaldi PA, Berndt MC.
    Thromb Haemost; 1989 Nov 24; 62(3):977-83. PubMed ID: 2512684
    [Abstract] [Full Text] [Related]

  • 5. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
    Nurden AT, Rosa JP, Fournier D, Legrand C, Didry D, Parquet A, Pidard D.
    J Clin Invest; 1987 Mar 24; 79(3):962-9. PubMed ID: 3818957
    [Abstract] [Full Text] [Related]

  • 6. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
    Grimaldi CM, Chen F, Wu C, Weiss HJ, Coller BS, French DL.
    Blood; 1998 Mar 01; 91(5):1562-71. PubMed ID: 9473221
    [Abstract] [Full Text] [Related]

  • 7. A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa.
    Tanoue K, Hasegawa S, Yamaguchi A, Yamamoto N, Yamazaki H.
    Thromb Res; 1987 Aug 01; 47(3):323-33. PubMed ID: 3629560
    [Abstract] [Full Text] [Related]

  • 8. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
    Grimaldi CM, Chen F, Scudder LE, Coller BS, French DL.
    Blood; 1996 Sep 01; 88(5):1666-75. PubMed ID: 8781422
    [Abstract] [Full Text] [Related]

  • 9. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F, Stierlé A, Fournier D, Morales M, André G, Nurden AT, Cazenave JP.
    J Clin Invest; 1992 Jun 01; 89(6):1995-2004. PubMed ID: 1602006
    [Abstract] [Full Text] [Related]

  • 10. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.
    Burk CD, Newman PJ, Lyman S, Gill J, Coller BS, Poncz M.
    J Clin Invest; 1991 Jan 01; 87(1):270-6. PubMed ID: 1702098
    [Abstract] [Full Text] [Related]

  • 11. Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies.
    Niessner H, Clemetson KJ, Panzer S, Mueller-Eckhardt C, Santoso S, Bettelheim P.
    Blood; 1986 Aug 01; 68(2):571-6. PubMed ID: 3015287
    [Abstract] [Full Text] [Related]

  • 12. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
    Hardisty R, Pidard D, Cox A, Nokes T, Legrand C, Bouillot C, Pannocchia A, Heilmann E, Hourdillé P, Bellucci S.
    Blood; 1992 Aug 01; 80(3):696-708. PubMed ID: 1638023
    [Abstract] [Full Text] [Related]

  • 13. A variant of Glanzmann's thrombasthenia which fails to express a GPIIb-IIIa related epitope that is recognized by a specific monoclonal antibody (C17).
    Escolar G, Diaz-Ricart M, Garrido M, Reverter JC, Villamor N, Sanz C, Maragall S, Castillo R, Ordinas A, Nurden AT.
    Br J Haematol; 1992 Aug 01; 81(4):545-51. PubMed ID: 1382548
    [Abstract] [Full Text] [Related]

  • 14. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia.
    Bray PF, Shuman MA.
    Blood; 1990 Feb 15; 75(4):881-8. PubMed ID: 1967954
    [Abstract] [Full Text] [Related]

  • 15. Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb.
    Poncz M, Rifat S, Coller BS, Newman PJ, Shattil SJ, Parrella T, Fortina P, Bennett JS.
    J Clin Invest; 1994 Jan 15; 93(1):172-9. PubMed ID: 8282784
    [Abstract] [Full Text] [Related]

  • 16. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
    Ruiz C, Liu CY, Sun QH, Sigaud-Fiks M, Fressinaud E, Muller JY, Nurden P, Nurden AT, Newman PJ, Valentin N.
    Blood; 2001 Oct 15; 98(8):2432-41. PubMed ID: 11588040
    [Abstract] [Full Text] [Related]

  • 17. Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition.
    Macchi L, Nurden P, Marit G, Bihour C, Clofent-Sanchez G, Combrié R, Nurden AT.
    Am J Hematol; 1998 Feb 15; 57(2):164-75. PubMed ID: 9462551
    [Abstract] [Full Text] [Related]

  • 18. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking.
    Coller BS, Seligsohn U, West SM, Scudder LE, Norton KJ.
    Blood; 1991 Nov 15; 78(10):2603-10. PubMed ID: 1726706
    [Abstract] [Full Text] [Related]

  • 19. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation.
    Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA.
    Blood; 1986 Jul 15; 68(1):275-80. PubMed ID: 2941084
    [Abstract] [Full Text] [Related]

  • 20. Dysfunctional platelet glycoprotein IIb/IIIa associated with a platelet release defect: a family study.
    Kamiyama M, Arkel YS, Lynch J, Chen K, Kunicki J.
    Am J Hematol; 1993 Apr 15; 42(4):395-7. PubMed ID: 8493993
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.